Oscar Health (OSCR) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

OSCR Stock Forecast

Oscar Health stock forecast is as follows: an average price target of $28.00 (represents a 103.42% upside from OSCR’s last price of $13.76) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

OSCR Price Target

The average price target for Oscar Health (OSCR) is $28.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $28.00 to $28.00. This represents a potential 103.42% upside from OSCR's last price of $13.76.

OSCR Analyst Ratings

Buy

According to 6 Wall Street analysts, Oscar Health's rating consensus is 'Buy'. The analyst rating breakdown for OSCR stock is 0 'Strong Buy' (0.00%), 3 'Buy' (50.00%), 3 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Oscar Health Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 08, 2024	Jessica Tassan	Piper Sandler	$28.00	$18.38	52.34%	103.42%
Jun 25, 2024	Jessica Tassan	Piper Sandler	$25.00	$17.64	41.72%	81.63%
Jun 12, 2024	Stephen Baxter	Wells Fargo	$27.00	$20.01	34.93%	96.16%
Jun 10, 2024	Nathan Rich	Goldman Sachs	$21.00	$20.21	3.91%	52.57%
Mar 21, 2024	John Ransom	Raymond James	$20.00	$13.76	45.35%	45.30%
Nov 15, 2022	Stephen Baxter	Wells Fargo	$4.00	$2.89	38.41%	-70.94%
Nov 14, 2022		Morgan Stanley	$5.00	$2.95	69.49%	-63.67%
Sep 01, 2022		Morgan Stanley	$9.00	$6.04	48.88%	-34.61%
Jun 09, 2022		Morgan Stanley	$12.00	$5.22	129.89%	-12.82%

The latest Oscar Health stock forecast, released on Aug 08, 2024 by Jessica Tassan from Piper Sandler, set a price target of $28.00, which represents a 52.34% increase from the stock price at the time of the forecast ($18.38), and a 103.42% increase from OSCR last price ($13.76).

Oscar Health Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	5
Avg Price Target	-	-	$24.20
Last Closing Price	$13.76	$13.76	$13.76
Upside/Downside	-100.00%	-100.00%	75.82%

In the current month, the average price target of Oscar Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Oscar Health's last price of $13.76. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 07, 2024	Sandler O'Neill	Underperform	Underperform	Hold
Oct 07, 2024	UBS	Neutral	Neutral	Hold
Oct 07, 2024	UBS		Neutral	Initialise
Sep 10, 2024	Sandler O'Neil	Underperform	Underperform	Hold
Sep 10, 2024	Sandler O'Neill	Overweight	Overweight	Hold
Aug 08, 2024	Wells Fargo	Buy	Buy	Hold
Aug 08, 2024	Piper Sandler	Overweight	Overweight	Hold
Jun 25, 2024	Piper Sandler		Overweight	Initialise
Jun 12, 2024	Wells Fargo	Overweight	Overweight	Hold
Jun 10, 2024	Goldman Sachs	Neutral	Neutral	Hold
May 20, 2024	Bank of America Securities	Buy	Buy	Hold
Jun 06, 2023	Bank of America Securities		Neutral	Upgrade
May 17, 2023	Wells Fargo	Overweight	Overweight	Hold
Nov 15, 2022	Wells Fargo		Overweight	Upgrade
Nov 14, 2022	Morgan Stanley	Overweight	Equal-Weight	Downgrade
Sep 01, 2022	Morgan Stanley	Overweight	Overweight	Hold
Jun 09, 2022	Morgan Stanley	Overweight	Overweight	Hold

Oscar Health's last stock rating was published by Sandler O'Neill on Oct 07, 2024. The company gave OSCR a "Underperform" rating, the same as its previous rate.

Oscar Health Financial Forecast

Oscar Health Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.43B	$1.44B	$1.52B	$1.47B	$1.04B	$40.09M	$1.02B	$1.01B	$520.33M	$462.19M	$549.75M	$388.69M
Avg Forecast	$3.19B	$3.18B	$3.12B	$3.02B	$2.81B	$2.83B	$2.84B	$2.80B	$2.92B	$2.91B	$2.88B	$2.76B	$2.46B	$2.33B	$2.13B	$1.99B	$1.43B	$1.42B	$1.38B	$1.27B	$1.18B	$1.07B	$1.10B	$1.03B	$564.51M	$543.73M	$588.30M	$597.79M
High Forecast	$3.29B	$3.29B	$3.23B	$3.12B	$2.90B	$2.92B	$2.93B	$2.89B	$3.02B	$3.00B	$2.98B	$2.88B	$2.47B	$2.36B	$2.20B	$2.06B	$1.47B	$1.43B	$1.43B	$1.31B	$1.21B	$1.07B	$1.10B	$1.03B	$564.51M	$543.73M	$588.30M	$597.79M
Low Forecast	$3.09B	$3.09B	$3.03B	$2.93B	$2.73B	$2.75B	$2.75B	$2.72B	$2.84B	$2.82B	$2.80B	$2.66B	$2.45B	$2.29B	$2.07B	$1.93B	$1.38B	$1.42B	$1.34B	$1.23B	$1.14B	$1.07B	$1.10B	$1.03B	$564.51M	$543.73M	$588.30M	$597.79M
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	4	2	2	1	1	3	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00%	1.01%	1.10%	1.15%	0.88%	0.04%	0.93%	0.98%	0.92%	0.85%	0.93%	0.65%

Oscar Health's average Quarter revenue forecast for Mar 24 based on 1 analysts is $1.99B, with a low forecast of $1.93B, and a high forecast of $2.06B. OSCR's average Quarter revenue forecast represents a 39.05% increase compared to the company's last Quarter revenue of $1.43B (Dec 23).

Oscar Health EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	4	2	2	1	1	3	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-145.48M	$-58.24M	$-6.53M	$-25.36M	$-216.89M	$-181.11M	$-102.04M	$-65.61M	$-194.67M	$-209.30M	$-68.66M	$-79.31M
Avg Forecast	$-1.01B	$-1.01B	$-987.72M	$-954.49M	$-888.74M	$-894.49M	$-896.35M	$-885.77M	$-923.68M	$-919.14M	$-911.48M	$-873.90M	$-777.81M	$-736.49M	$-674.36M	$-46.51M	$-451.07M	$-449.61M	$-437.79M	$-42.29M	$-265.38M	$-341.77M	$-350.58M	$-38.44M	$-180.60M	$-173.95M	$-188.21M	$-64.26M
High Forecast	$-977.54M	$-977.14M	$-958.71M	$-926.46M	$-862.63M	$-868.21M	$-870.02M	$-859.76M	$-896.55M	$-892.14M	$-884.71M	$-839.57M	$-774.65M	$-725.44M	$-654.56M	$-37.21M	$-437.83M	$-447.81M	$-424.93M	$-33.83M	$-212.30M	$-341.77M	$-350.58M	$-30.75M	$-180.60M	$-173.95M	$-188.21M	$-51.41M
Low Forecast	$-1.04B	$-1.04B	$-1.02B	$-986.13M	$-918.19M	$-924.13M	$-926.06M	$-915.13M	$-954.29M	$-949.60M	$-941.69M	$-911.35M	$-780.98M	$-747.55M	$-696.71M	$-55.82M	$-466.02M	$-451.87M	$-452.30M	$-50.74M	$-318.45M	$-341.77M	$-350.58M	$-46.13M	$-180.60M	$-173.95M	$-188.21M	$-77.12M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.32%	0.13%	0.01%	0.60%	0.82%	0.53%	0.29%	1.71%	1.08%	1.20%	0.36%	1.23%

undefined analysts predict OSCR's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Oscar Health's previous annual EBITDA (undefined) of $NaN.

Oscar Health Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	4	2	2	1	1	3	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-150.03M	$-65.40M	$-15.53M	$-39.63M	$-226.56M	$-193.55M	$-112.13M	$-77.32M	$-197.74M	$-212.75M	$-73.07M	$-87.37M
Avg Forecast	$-34.80M	$63.49M	$164.39M	$227.54M	$-69.26M	$26.05M	$93.13M	$168.85M	$-82.14M	$16.67M	$95.28M	$162.11M	$-143.47M	$-41.67M	$39.30M	$-53.27M	$-175.64M	$-114.87M	$-53.85M	$-48.43M	$-271.18M	$-218.56M	$-145.50M	$-44.03M	$-297.42M	$-220.80M	$-142.26M	$-70.80M
High Forecast	$-33.47M	$66.22M	$171.47M	$237.34M	$-66.61M	$27.17M	$97.14M	$176.13M	$-79.00M	$17.38M	$99.39M	$213.57M	$-121.21M	$-40.08M	$39.34M	$-42.62M	$-168.94M	$-96.85M	$-51.79M	$-38.75M	$-216.94M	$-218.56M	$-145.50M	$-35.22M	$-297.42M	$-220.80M	$-142.26M	$-56.64M
Low Forecast	$-36.30M	$61.06M	$158.11M	$218.85M	$-72.24M	$25.06M	$89.57M	$162.40M	$-85.68M	$16.03M	$91.64M	$113.22M	$-168.21M	$-43.46M	$39.26M	$-63.93M	$-183.21M	$-128.38M	$-56.17M	$-58.12M	$-325.42M	$-218.56M	$-145.50M	$-52.83M	$-297.42M	$-220.80M	$-142.26M	$-84.96M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.85%	0.57%	0.29%	0.82%	0.84%	0.89%	0.77%	1.76%	0.66%	0.96%	0.51%	1.23%

Oscar Health's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OSCR's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Oscar Health SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	4	2	2	1	1	3	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$85.61M	$75.50M	$76.45M	$102.15M	$75.81M	$78.56M	$80.75M	$74.66M	$89.34M	$61.27M	$50.91M	$63.06M
Avg Forecast	$480.07M	$479.87M	$470.82M	$454.98M	$423.64M	$426.38M	$427.26M	$422.22M	$440.29M	$438.13M	$434.48M	$416.56M	$370.76M	$351.07M	$321.45M	$52.93M	$215.01M	$214.32M	$208.68M	$48.12M	$121.79M	$160.99M	$165.15M	$43.74M	$85.07M	$81.94M	$88.66M	$51.10M
High Forecast	$495.98M	$495.77M	$486.42M	$470.06M	$437.68M	$440.51M	$441.43M	$436.22M	$454.88M	$452.65M	$448.88M	$434.42M	$372.27M	$356.34M	$332.10M	$63.51M	$222.14M	$215.39M	$215.60M	$57.74M	$146.15M	$160.99M	$165.15M	$52.49M	$85.07M	$81.94M	$88.66M	$61.32M
Low Forecast	$465.97M	$465.77M	$456.99M	$441.62M	$411.19M	$413.85M	$414.72M	$409.82M	$427.36M	$425.26M	$421.72M	$400.20M	$369.26M	$345.80M	$312.01M	$42.34M	$208.70M	$213.46M	$202.55M	$38.49M	$97.43M	$160.99M	$165.15M	$34.99M	$85.07M	$81.94M	$88.66M	$40.88M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.40%	0.35%	0.37%	2.12%	0.62%	0.49%	0.49%	1.71%	1.05%	0.75%	0.57%	1.23%

Oscar Health's average Quarter SG&A projection for Mar 24 is $52.93M, based on 1 Wall Street analysts, with a range of $42.34M to $63.51M. The forecast indicates a -38.17% fall compared to OSCR last annual SG&A of $85.61M (Dec 23).

Oscar Health EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	4	2	2	1	1	3	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.66	$-0.29	$-0.07	$-0.18	$-1.05	$-0.91	$-0.53	$-0.37	$-0.94	$-1.02	$-0.35	$-0.98
Avg Forecast	$-0.14	$0.26	$0.68	$0.94	$-0.28	$0.11	$0.38	$0.69	$-0.34	$0.07	$0.39	$0.67	$-0.59	$-0.17	$0.16	$0.27	$-0.72	$-0.47	$-0.22	$-0.06	$-1.14	$-0.72	$-0.48	$-0.21	$-0.98	$-0.73	$-0.47	$-0.53
High Forecast	$-0.14	$0.27	$0.71	$0.98	$-0.27	$0.11	$0.40	$0.72	$-0.32	$0.07	$0.41	$0.88	$-0.50	$-0.16	$0.16	$0.28	$-0.69	$-0.40	$-0.21	$-0.06	$-1.09	$-0.72	$-0.48	$-0.21	$-0.98	$-0.73	$-0.47	$-0.53
Low Forecast	$-0.15	$0.25	$0.65	$0.90	$-0.30	$0.10	$0.37	$0.67	$-0.35	$0.07	$0.38	$0.47	$-0.69	$-0.18	$0.16	$0.26	$-0.75	$-0.53	$-0.23	$-0.06	$-1.18	$-0.72	$-0.48	$-0.21	$-0.98	$-0.73	$-0.47	$-0.53
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.91%	0.61%	0.32%	2.97%	0.92%	1.27%	1.11%	1.73%	0.96%	1.40%	0.75%	1.83%

According to undefined Wall Street analysts, Oscar Health's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OSCR previous annual EPS of $NaN (undefined).

Oscar Health Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
OSCR	Oscar Health	$13.50	$28.00	107.41%	Buy
CVS	CVS Health	$44.04	$73.50	66.89%	Buy
CI	Cigna	$265.59	$400.00	50.61%	Buy
ELV	Elevance Health	$366.30	$542.14	48.00%	Buy
CNC	Centene	$57.81	$81.50	40.98%	Buy
CLOV	Clover Health Investments	$3.21	$4.25	32.40%	Hold
UNH	UnitedHealth Group	$485.52	$618.75	27.44%	Buy
HUM	Humana	$233.89	$292.13	24.90%	Hold
MOH	Molina Healthcare	$291.78	$347.00	18.93%	Hold
ALHC	Alignment Healthcare	$10.83	$10.00	-7.66%	Buy

OSCR Forecast FAQ

Is Oscar Health a good buy?

Yes, according to 6 Wall Street analysts, Oscar Health (OSCR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 50.00% of OSCR's total ratings.

What is OSCR's price target?

Oscar Health (OSCR) average price target is $28 with a range of $28 to $28, implying a 103.42% from its last price of $13.76. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Oscar Health stock go up soon?

According to Wall Street analysts' prediction for OSCR stock, the company can go up by 103.42% (from the last price of $13.76 to the average price target of $28), up by 103.42% based on the highest stock price target, and up by 103.42% based on the lowest stock price target.

Can Oscar Health stock reach $20?

OSCR's average twelve months analyst stock price target of $28 supports the claim that Oscar Health can reach $20 in the near future.

What are Oscar Health's analysts' financial forecasts?

Oscar Health's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $11.28B (high $11.65B, low $10.95B), average EBITDA is $-3.565B (high $-3.461B, low $-3.684B), average net income is $218.77M (high $233.83M, low $204.79M), average SG&A $1.7B (high $1.76B, low $1.65B), and average EPS is $0.9 (high $0.962, low $0.842). OSCR's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $12.51B (high $12.93B, low $12.15B), average EBITDA is $-3.956B (high $-3.84B, low $-4.087B), average net income is $420.61M (high $441.56M, low $401.72M), average SG&A $1.89B (high $1.95B, low $1.83B), and average EPS is $1.73 (high $1.82, low $1.65).

Did the OSCR's actual financial results beat the analysts' financial forecasts?

Based on Oscar Health's last annual report (Dec 2023), the company's revenue was $5.86B, beating the average analysts forecast of $5.5B by 6.50%. Apple's EBITDA was $-236M, missing the average prediction of $-1.381B by -82.94%. The company's net income was $-271M, missing the average estimation of $-393M by -31.08%. Apple's SG&A was $339.72M, missing the average forecast of $686.13M by -50.49%. Lastly, the company's EPS was $-1.22, missing the average prediction of $-1.477 by -17.40%. In terms of the last quarterly report (Dec 2023), Oscar Health's revenue was $1.43B, beating the average analysts' forecast of $1.43B by 0.35%. The company's EBITDA was $-145M, missing the average prediction of $-451M by -67.75%. Oscar Health's net income was $-150M, missing the average estimation of $-176M by -14.58%. The company's SG&A was $85.61M, missing the average forecast of $215.01M by -60.18%. Lastly, the company's EPS was $-0.66, missing the average prediction of $-0.723 by -8.65%